Tanvex BioPharma (6541.TW) Q2 2026 Earnings

8MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-1.61
-1.33
-1.05
-0.76

Details

Expected EPS
-1.6149608736
Actual EPS
N/A
Surprise EPS
1.61
Surprise Percent
+100%

Description

Tanvex BioPharma (6541.TW) will report earnings of for Q2 2026 on May 08, 2026.

0 Comments

Share your thoughts